These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2474122)

  • 1. GP38, P28-I and P28-II: candidates for a vaccine against schistosomiasis.
    Pierce RJ; Balloul JM; Grzych JM; Dissous C; Auriault C; Boulanger D; Capron M; Sondermeyer P; Lecocq JP; Capron A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():111-4. PubMed ID: 2474122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis.
    Balloul JM; Grzych JM; Pierce RJ; Capron A
    J Immunol; 1987 May; 138(10):3448-53. PubMed ID: 3106483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni gene GP22 encodes the tegumental antigen sm25: (1) antibodies to a predicted B-cell epitope of Sm25 cross-react with other candidate vaccine worm antigens; (2) characterization of a recombinant product containing tandem-repeats of this peptide as a vaccine.
    Petzke MM; Suri PK; Bungiro R; Goldberg M; Taylor SF; Ranji S; Taylor H; McCray JW; Knopf PM
    Parasite Immunol; 2000 Aug; 22(8):381-95. PubMed ID: 10972845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
    de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
    Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell responsiveness towards various synthetic peptides of the P28 antigen in rat and mouse models during Schistosoma mansoni infection.
    Wolowczuk I; Auriault C; Gras-Masse H; Mazingue C; Vendeville C; Tartar A; Capron A
    Int Arch Allergy Appl Immunol; 1990; 93(4):350-8. PubMed ID: 1713570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent.
    Soisson LA; Reid GD; Farah IO; Nyindo M; Strand M
    J Immunol; 1993 Nov; 151(9):4782-9. PubMed ID: 8409436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides.
    Auriault C; Gras-Masse H; Pierce RJ; Butterworth AE; Wolowczuk I; Capron M; Ouma JH; Balloul JM; Khalife J; Neyrinck JL
    J Clin Microbiol; 1990 Sep; 28(9):1918-24. PubMed ID: 2121788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning of a protective antigen of schistosomes.
    Balloul JM; Sondermeyer P; Dreyer D; Capron M; Grzych JM; Pierce RJ; Carvallo D; Lecocq JP; Capron A
    Nature; 1987 Mar 12-18; 326(6109):149-53. PubMed ID: 2434863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
    Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
    Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of recombinant protein r140, a polypeptide segment of tegumental glycoprotein Sm25, as a defined antigen vaccine against Schistosoma mansoni.
    Suri PK; Goldberg M; Madikizela M; Petzke MM; Bungiro RD; Davies SJ; Chakraborty B; Nguyen KB; McCray JW; Knopf PM
    Parasite Immunol; 1997 Nov; 19(11):515-29. PubMed ID: 9427998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. 1. Partial protection of Fischer rat after active immunization.
    Wolowczuk I; Auriault C; Bossus M; Boulanger D; Gras-Masse H; Mazingue C; Pierce RJ; Grezel D; Reid GD; Tartar A
    J Immunol; 1991 Mar; 146(6):1987-95. PubMed ID: 1900878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.
    Karmakar S; Zhang W; Ahmad G; Torben W; Alam MU; Le L; Damian RT; Wolf RF; White GL; Carey DW; Carter D; Reed SG; Siddiqui AA
    Vaccine; 2014 Mar; 32(11):1296-303. PubMed ID: 24397898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
    Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
    Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigen.
    Wolowczuk I; Auriault C; Gras-Masse H; Vendeville C; Balloul JM; Tartar A; Capron A
    J Immunol; 1989 Feb; 142(4):1342-50. PubMed ID: 2492579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice.
    Yang W; Jackson DC; Zeng Q; McManus DP
    Vaccine; 2000 Aug; 19(1):103-13. PubMed ID: 10924792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of protective and non-protective surface membrane carbohydrate epitopes of Schistosoma mansoni.
    Ko AI; Harn DA
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():115-9. PubMed ID: 2474123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mimotope peptide-based vaccine against Schistosoma mansoni: synthesis and characterization.
    Arnon R; Tarrab-Hazdai R; Steward M
    Immunology; 2000 Dec; 101(4):555-62. PubMed ID: 11122460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.